Psychedelic Drugs Market

Report - ID620338 | 09 July, 2019 | Healthcare | 100 pages | Report Type (Global) | Publisher Name - 99Strategy

The global  Psychedelic Drugs market will reach xxx Million USD in 2020 and CAGR xx% 2020-2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of  Psychedelic Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Durg Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
•    Lysergic Acid Diethylamide (LSD)
•    3,4-MethylEnedioxyMethamphetamine (Ecstasy)
•    Phencyclidine
•    Gamma Hydroxybutyric Acid (GHB)
•    Ketamine
•    Ayahuasca
•    Salvia
•    Psilocybin
•    Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Some  of the leading competitors currently working in the global psychedelic drugs market are COMPASS, The Emmes Company, LLC, Klarisana,  AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, ALLERGAN, H. Lundbeck A/S among others.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
•    Major Depressive Disorder
•    Resistant depression
•    Panic disorder
•    Post-traumatic stress disorder
•    Opiate Addiction
•    Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
•    North America (U.S., Canada, Mexico)
•    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
•    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

Leave a Message